Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itsuro Endo

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Clinical Calcium|June 29, 2018
[Body weight and bone/calcium metabolism. FSH and obesity, osteoporosis.]Itsuro Endo
Clinical Calcium|March 25, 2017
[Calcilytic drugs:Feature and future.]Itsuro Endo
Clinical Calcium|February 27, 2015
[Current Topics on Vitamin D. Combined therapy of anti-resorptive drug and active vitamin D]Itsuro Endo
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 17, 2014
[Metabolic bone and joint diseases]Itsuro Endo
Clinical Calcium|September 2, 2014
[Glucocorticoid and Bone. The effect of glucocorticoid and PTH in osteoblast apoptosis and differentiation via interleukin 11 expression]Itsuro Endo
Clinical Calcium|June 30, 2015
[Bone and Nutrition. A prospect of calcium sensing receptor]Itsuro Endo
Clinical Calcium|June 2, 2009
[Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)]Itsuro Endo
Clinical Calcium|December 27, 2013
[Anti-sclerostin antibody : its bone formation effect and therapeutic potential for osteoporosis]Itsuro Endo
Clinical Calcium|January 28, 2016
[Epidemiology of FGF23-related hypophosophatemic diseases]Itsuro Endo
Journal of Bone and Mineral Metabolism|October 15, 2020
RANKL as a target for the treatment of osteoporosisToshio Matsumoto, Itsuro Endo
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Clinical Calcium|June 29, 2018
[Body weight and bone/calcium metabolism. FSH and obesity, osteoporosis.]Itsuro Endo
Clinical Calcium|March 25, 2017
[Calcilytic drugs:Feature and future.]Itsuro Endo
Clinical Calcium|February 27, 2015
[Current Topics on Vitamin D. Combined therapy of anti-resorptive drug and active vitamin D]Itsuro Endo
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 17, 2014
[Metabolic bone and joint diseases]Itsuro Endo
Clinical Calcium|September 2, 2014
[Glucocorticoid and Bone. The effect of glucocorticoid and PTH in osteoblast apoptosis and differentiation via interleukin 11 expression]Itsuro Endo
Clinical Calcium|June 30, 2015
[Bone and Nutrition. A prospect of calcium sensing receptor]Itsuro Endo
Clinical Calcium|June 2, 2009
[Clinical aspect of recent progress in phosphate metabolism. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23)]Itsuro Endo
Clinical Calcium|December 27, 2013
[Anti-sclerostin antibody : its bone formation effect and therapeutic potential for osteoporosis]Itsuro Endo
Clinical Calcium|January 28, 2016
[Epidemiology of FGF23-related hypophosophatemic diseases]Itsuro Endo
Journal of Bone and Mineral Metabolism|October 15, 2020
RANKL as a target for the treatment of osteoporosisToshio Matsumoto, Itsuro Endo
Pageof 12